🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Acceptability and Benefits of an Onco-sexology Program for Laryngectomy Patients and Their Partners

Recruitingn/aAges 18 Years - anyAllInstitut Claudius Regaud
NCT06517355 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Single-centre prospective pilot study designed to demonstrate the acceptability of onco-sexology management for laryngectomy patients and their partners in order to improve their perception of their intimate life. This is a non-interventional study (category 3 Loi Jardé), which will not result in any change in patient management. All procedures will be carried out in accordance with standard practice. Patients will be followed for 14 months.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: For patients: 1. Patient to be treated for ORL cancer by total (pharyngo)laryngectomy 2. Patient WHO 0-1-2 3. Age greater than or equal to 18 years 4. Patient who has not objected to participation in the study. For partners (if applicable) : 1. Age greater than or equal to 18 years 2. Subject who has not objected to participation in the study. Exclusion Criteria: For patients: 1. Patient with another co-existing malignant disease at the time of inclusion. 2. Any psychological, familial, geographical or sociological condition that does not allow for compliance with the medical follow-up and/or procedures foreseen in the study protocol. 3. Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice). For partners (if applicable): 1\. Patients deprived of their liberty or under legal protection (guardianship and tutorship, safeguard of justice).
💊

What it tests

  • In this research, the procedure under study is represented:
📍

Where

1 site
IUCT-O
Toulouse, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy